Cigna CEO Cordani on Earnings, Covid, Insurance Coverage

The video features a discussion with the CEO of Cigna about healthcare trends for 2023. Key topics include expectations for medical cost trends, the impact of respiratory viruses like flu and COVID, the role of biosimilars in cost savings, and the expansion of Medicare Advantage and ACA markets. The CEO also addresses the transition to commercial pricing for COVID vaccines and the growth of Evernorth's digital health services.

What is the primary reason for the expected increase in medical costs in 2023?

• More frequent doctor visits

• Higher hospital labor costs

• Rising insurance premiums

• Increased pharmaceutical prices

How do respiratory viruses like COVID-19 and flu impact overall medical costs?

• They significantly drive up costs

• They have no impact on costs

• They have a minor impact on costs

• They reduce medical costs

What is the expected impact of biosimilars on Cigna's business in 2023?

• They will drive cost savings and earnings

• They will increase costs

• They will decrease earnings

• They will have no impact

What is Cigna's approach to covering Amgen's biosimilar version of Humira?

• Coverage only for biosimilars

• Co-preferred coverage with choice

• No coverage for biosimilars

• Exclusive coverage of Humira

How might political changes in Washington affect Medicare Advantage?

• They might result in entitlement reform

• They could lead to program expansion

• They will have no effect

• They will reduce benefits

What is the significance of the Inflation Reduction Act for the ACA?

• It reduces subsidies

• It increases insurance premiums

• It extends subsidies through 2025

• It eliminates the ACA

What is a key focus of Evernorth's digital health services?

• Exclusive in-person care

• Reducing digital health options

• Fragmented care solutions

• Coordinated care with other services